CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chairman & CEO sold 56,159 shares at an average $23.05 ($1,294,534)
- SC 13G/A Stake Amended Statement of Ownership
- CT ORDER Other Confidential Order
- 4 Open-market sale EVP & Chief Legal Officer sold 2,477 shares at $22.09 ($54,717)
- 8-K Event Results of operations
- 4 Shares withheld for taxes Interim CFO gave up 1,297 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 2,161 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- D/A Other Amended Notice of Exempt Offering of Securities
- 8-K Event Material agreement
- SC 13G/A Stake Amended Statement of Ownership
Page 29 of 39 · 778 filings